The Birth Of “The Biotech Tourist”
“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,”…
“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,”…
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…
It should come as no surprise that one of the top biotech stocks to consider right now, as identified by the author of today’s article,…
While the broader market has been all over the place over the past few months, one area that has performed significantly better than the S&P…
Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those…
After three straight months of losses, April brought the S&P 500 health care sector its best one-month gain in twenty years, and today’s article notes…
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…
In assessing the current market environment, the author of today’s article notes that “it becomes apparent that there’s an opportunity for those able to take…
The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…
While the COVID-19 pandemic is far from over, there have been some small glimmers of hope in recent days – and the market responded accordingly.…